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Abstract
Background: Heart failure places a significant burden on patients and health systems in high-income countries. However,
information about its burden in low- and middle-income countries (LMICs) is scant. We thus set out to review both
published and unpublished information on the presentation, causes, management, and outcomes of heart failure in LMICs.
Methods and Findings: Medline, Embase, Global Health Database, and World Health Organization regional databases were
searched for studies from LMICs published between 1 January 1995 and 30 March 2014. Additional unpublished data were
requested from investigators and international heart failure experts. We identified 42 studies that provided relevant information on
acute hospital care (25 LMICs; 232,550 patients) and 11 studies on the management of chronic heart failure in primary care or
outpatient settings (14 LMICs; 5,358 patients). The mean age of patients studied ranged from 42 y in Cameroon and Ghana to 75 y
in Argentina, and mean age in studies largely correlated with the human development index of the country in which they were
conducted (r = 0.71, p,0.001). Overall, ischaemic heart disease was the main reported cause of heart failure in all regions except
Africa and the Americas, where hypertension was predominant. Taking both those managed acutely in hospital and those in non-
acute outpatient or community settings together, 57% (95% confidence interval [CI]: 49%–64%) of patients were treated with
angiotensin-converting enzyme inhibitors, 34% (95% CI: 28%–41%) with beta-blockers, and 32% (95% CI: 25%–39%) with
mineralocorticoid receptor antagonists. Mean inpatient stay was 10 d, ranging from 3 d in India to 23 d in China. Acute heart failure
accounted for 2.2% (range: 0.3%–7.7%) of total hospital admissions, and mean in-hospital mortality was 8% (95% CI: 6%–10%). There
was substantial variation between studies (p,0.001 across all variables), and most data were from urban tertiary referral centres.
Only one population-based study assessing incidence and/or prevalence of heart failure was identified.
Conclusions: The presentation, underlying causes, management, and outcomes of heart failure vary substantially across LMICs. On
average, the use of evidence-based medications tends to be suboptimal. Better strategies for heart failure surveillance and
management in LMICs are needed.
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Introduction
In high-income countries (HICs), heart failure is a well-
recognized public health problem representing a significant
burden for patients and healthcare systems [1,2]. For example,
in the UK and US, heart failure is one of the leading causes of
hospitalisation, and despite recent advances, outcomes remain
poor [3–6]. Of those hospitalised for heart failure in the UK,
about 10% will die during admission [6]. In the US, between 20%
and 27% of those who survive to discharge will be re-admitted
within 30 d [7], whilst 5-y mortality rates range between 40% and
65% amongst the US, UK, Netherlands, and Sweden [2–4,8,9].
The costs associated with heart failure care are also substantial. In
many HICs, heart failure typically consumes 1%–2% of
healthcare resources [2], mainly because of repeated admissions
to hospitals and prolonged inpatient stays.
With demographic changes and the epidemiological transition
to non-communicable diseases [10,11], heart failure is expected to
become a major public health issue in low- and middle-income
countries (LMICs). Yet systematic evidence for its current burden
to patients and health services is limited [1,2,12]. In fact, the last
review of the burden of heart failure in LMICs, conducted over
ten years ago, found no population studies and concluded that
published data on heart failure epidemiology were almost entirely
absent from most populations across the world [12]. As a result,
many of our assumptions regarding the current burden of this
condition worldwide are based on extrapolations from studies
conducted in HICs, which may not be appropriate [1,2].
Therefore, we sought to conduct a systematic review of both
published and unpublished data regarding the patterns of heart
failure presentation, management, and outcomes in LMICs.
Methods
This systematic review was designed and undertaken according
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines [13]. A study protocol
describing the methodology has been published previously [14].
In brief, we searched Medline, Embase, Global Health Database,
and WHO regional databases for articles published between 1
January 1995 and 30 March 2014 with the subject terms ‘‘heart
failure’’ or ‘‘cardiomyopathies’’ or any related terms AND
‘‘incidence’’, ‘‘prevalence’’, ‘‘cause*’’, ‘‘etiology’’, ‘‘aetiology’’,
‘‘epidemiolog*’’, ‘‘burden’’, ‘‘management’’, ‘‘treatment’’, ‘‘pre-
vent*’’, ‘‘population based’’, ‘‘community’’, ‘‘trends’’, ‘‘survey’’,
‘‘surveillance’’, ‘‘mortality’’, ‘‘morbidity’’, ‘‘fatalit*’’, or ‘‘attack
rate’’. Relevant studies from LMICs on the epidemiology,
diagnosis, management, and outcomes of heart failure were
included. There were no language restrictions. We also scrutinised
the reference lists of study reports and review articles, and inquired
among our collaborators and international heart failure experts
about any additional databases or studies of which they may be
aware. We further searched the Institute for Health Metrics and
Evaluation’s Global Health Data Exchange as well as the websites
of regional and country-specific societies of cardiology to identify
further datasets.
Figure 1 summarises the retrieval and selection process for studies
and relevant databases. After removing duplicate reports, two
reviewers independently screened all titles and abstracts for their
potential eligibility and extracted data using a pre-designed form.
Studies were eligible for inclusion if they reported on heart failure
patients from LMICs as defined by the World Bank [15]. Studies
must have reported on at least 100 cases and contained relevant
information on demographic characteristics, prevalence, case
fatality, underlying aetiology, or management of patients with heart
failure. Studies confined to subgroups of patients with heart failure
(for example, those that included only dilated cardiomyopathy or
heart failure as a complication of acute myocardial infarction) were
excluded, as were studies that clearly did not include a represen-
tative sample of patients from the setting chosen (for example,
studies that selected people referred to an echocardiography
department, or studies that excluded adult populations) [14].
Investigators of multinational studies that had not reported findings
by country were contacted for country-specific data.
Quality Assessment
In order to capture a comprehensive overview of heart failure in
LMICs, a wide range of studies, each with differing objectives and
designs, were included. Studies meeting the minimum quality
requirement, as specified below, for inclusion were analysed for
both methodological limitations and reporting quality, using items
from the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) guidelines [16] (Tables 1–6). Specifical-
ly, the sample size of each study, the location and type of
healthcare facility, diagnostic methods used, and patient selection
criteria were documented. In addition, we assessed each study’s
specific methodological strengths and weaknesses as well as likely
external validity.
Statistical Analysis
Study-specific data on percentages are presented as forest plots
with exact binomial 95% confidence intervals (CIs). These
percentages were pooled, by World Health Organization region
(Table 7) and across regions, using the random effects method of
DerSimonian and Laird [17]. Heterogeneity between studies was
quantified by the I2 statistic and tested using Cochran’s Q test.
Means were rarely reported with an estimate of variability, and,
consequently, we weighted individual means by study size in
pooled analyses, and present the pooled mean and the range of
means.
Patients presenting acutely to hospitals may differ in many
respects from those that are seen in clinics for chronic
management. When pooling the data we therefore indicate the
setting of each study in all forest plots. Studies from community
primary care or outpatient clinics were designated as non-acute,
and studies from inpatient populations, acute. Studies reporting
both inpatient and outpatient data were included in the non-acute
category. Additional subgroup analyses were performed by level of
country income and by study time period. For income level
analyses, studies were divided into low-income, low-middle-
income, and upper-middle-income groups according to World
Bank [15] country classification at the final year of the recruitment
period of the study. The relationship between a study’s mean age
at admission for heart failure and the human development index
(HDI) [18] for the country involved was estimated with linear
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regression analysis; the HDI was taken for the closest year to the
final year of patient recruitment for the studies representing each
country. The HDI is a composite measure of development
produced by the United Nations Development Programme that
incorporates life expectancy, education, and gross national income
per capita [18]. Random effects meta-regression was performed to
investigate study year as an explanation for the between-study
heterogeneity in causes of heart failure, management, and in-
hospital mortality. Corresponding bubble plots were drawn, with
the size of each bubble inversely proportional to the estimated
variance in the respective study.
Statistical analyses were done using R version 3.0.2 and Stata
version 11.2.
Results
Geographic Distribution and Study Description
Overall, 49 published studies [19–67] and four unpublished
datasets ([68–70]; S. Rahimzadeh, F. Farzadfar F, M. Ghaziani,
unpublished data) were included; their geographical distribution is
presented in Figure 2, and key study characteristics, divided by
WHO region, are summarised in Tables 1–6. We obtained
unpublished country datasets from the Acute Decompensated
Heart Failure Registry (ADHERE)–International [68] regarding
Malaysia and the Philippines, as well as the Identification of
Patients with Heart Failure and Preserved Systolic Function (I
PREFER) registry [70] including Iran, Lebanon, Egypt, Tunisia,
Algeria, Chile, Colombia, and Mexico. Additional unpublished
data were contributed from Iran (S. Rahimzadeh, F. Farzadfar F,
and M. Ghaziani, unpublished data) and India [69].
Most studies were based in a single hospital, although 21
datasets documented multi-centre studies in Algeria [70],
Argentina [21,43,44], Brazil [40,45], Chile [41,70], Colombia
[70], China [55,57,62], Egypt [70], Indonesia [20], India [69],
Iran (S. Rahimzadeh, F. Farzadfar F, and M. Ghaziani,
unpublished data; [70]), Lebanon [70], Thailand [52], Malaysia
[68], Mexico [70], Philippines [68], Romania [50], Tunisia [70],
Turkey [49,63,64], and a further nine countries in sub-Saharan
Africa [35]. Four studies involved both inpatient and outpatient
data [22,24,26,36], six studies referred solely to patients seen at
outpatient clinics [27,39,61,66,67,70], three studies described
heart failure in primary care settings [62–64], and the remainder
reported solely on inpatient populations. One study was a
population-based assessment of the prevalence of heart failure in
Turkey [63].
Case Identification and Ascertainment
The studies together included 237,908 episodes of heart failure
hospitalisation. The median number of cases across all studies was
386 (range: 100–194,098). Diagnosis of heart failure was
established according to the Framingham criteria [71] in 12
studies [21,22,24,28–31,42,48,55,62,70]. European Society of
Cardiology guidelines were used in eight studies [25–
27,41,50,54,60,61], the Boston criteria [72] in three studies
[39,40,47], and the American Heart Association guidelines in
two studies [49,53], and the diagnosis was left to the investigator’s
or examining physician’s discretion in 26 studies ([19,20,23,32–
38,43–46,51,52,56–58,64,65,67–69]; S. Rahimzadeh, F. Farzad-
far F, and M. Ghaziani, unpublished data). One study diagnosed
all cases of heart failure solely using echocardiography [59].
Information on the use of additional investigative tools, including
echocardiography, chest radiography, and electrocardiography,
was provided in 28 studies [19–21,24–26,28,31,35,39,41–
43,46,48–50,51,54,56,57,59,61,63,64,66,70,73]. Of these, 14 stud-
ies performed echocardiography on all patients [19,24–
26,28,35,46,48,53,54,59,61,63,66]. The mean left ventricular
ejection fraction (LVEF) was documented in 18 studies, reporting
data from Algeria [70], Egypt [70], Tunisia [70], Cameroon [24],
Ethiopia [35], Sudan [35], Mozambique [35], Kenya [35],
Uganda [35], Senegal [35], South Africa [25], Nigeria [26,28],
Brazil [19,39,42,46,66], Chile [41,70], Colombia [70], Mexico
[70], Romania [50], Serbia [61], Turkey [49], Iran [70], Lebanon
[70], Indonesia [20], Thailand [52], and China [53]. Across all
studies, mean LVEF was 40% (range: 27%–57%) (Table 8).
Hospitalised patients had a mean LVEF of 38% (27%–57%), with
a corresponding figure of 48% (29%–55%) in non-acute settings.
Demographic Characteristics
The demographic characteristics of patients and outcomes by
region are shown in Table 8. The corresponding data by country
are shown in Table 9. Men made up 58% (95% CI: 54%–62%) of
study participants (Figure 3). The mean age of patients for each
region ranged from just over 52 y (range: 42–64) in Africa to 70 y
(range: 53–77) in the Americas, and when combined across all
regions was 63 y (range: 42–77). The mean age of patients on
admission rose with the country income level. In low-income
countries, the corresponding figure was 50 y (range: 42–58), rising
to 60 y (range: 50–74) in low-middle-income countries, and
reaching 70 y (range: 54–77) in upper-middle-income countries.
Mean age also correlated with the HDI across countries (r = 0.71,
p,0.001) (Figure 4).
Causes of Heart Failure
Although most studies made a clear distinction between
aetiologies and co-morbidities, the categories reported were highly
variable, and multiple causes were often attributed to individual
cases of heart failure. Across all LMICs, non-communicable
diseases, and in particular ischaemic heart disease (IHD) and
hypertension, are the leading causes of heart failure (Table 10).
However, there is heterogeneity between the regions. IHD is the
most commonly reported cause of heart failure in all regions
except Africa and the Americas (Figures 5 and 6). In the Americas
hypertension and IHD are responsible for a similar percentage of
documented cases, at 31% (95% CI: 19%–43%, I2 99%, p for
heterogeneity ,0.001) and 33% (95% CI: 27%–38%, I2 96%, p,
0.001), respectively. In Africa, 8% (95% CI: 5%–11%, I2 98%, p,
0.001) of heart failure is due to IHD, with hypertension the
dominant cause, responsible for 46% (95% CI: 36%–55%, I2
98%, p,0.001) of cases. Cardiomyopathies cause 24% (95% CI:
20%–29%, I2 99%, p,0.001) of heart failure cases across LMICs
taken together (Figure 7). Idiopathic, hypertrophic, and restrictive
cardiomyopathies are reported across all countries; however, other
specific types of cardiomyopathies showed substantial regional
variation. Peri-partum and HIV-associated cardiomyopathies
were reported only in Africa. By contrast, Chagas cardiomyopathy
remains a Latin American phenomenon [21,43]. Valvular heart
disease is responsible for 18% (95% CI: 15%–22%, I2 98%, p,
0.001) of cases of heart failure across LMICs (Figure 8).
Management of Heart Failure
Amongst all studies, the management of heart failure varies
considerably between regions and within regions, as well as
between studies from the same country (Table 11). The most
commonly prescribed treatments are loop and/or thiazide
diuretics, prescribed for 69% (95% CI: 60%–78%, I2 100%, p,
0.001) of individuals in LMICs worldwide (Figure 9). Angiotensin-
converting enzyme inhibitors (ACEIs) are used in 57% (95% CI:
49%–64%, I2 100%, p,0.001) of cases, beta-blockers in 34%
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(95% CI: 28%–41%, I2 100%, p,0.001), and mineralocorticoid
receptor antagonists in 32% (95% CI: 25%–39%, I2 100%, p,
0.001) (Figures 10–12).
Outcomes
Across LMICs, patients admitted with heart failure remained in
hospital for a mean of 10 d (Table 8). The mean hospital stay
ranged from 3 d in India to 23 d amongst studies from China.
Wide differences were observed amongst Argentinian and
Brazilian studies. In Argentina, length of stay varied between
studies from 5 d to 25 d, with an overall mean of 7 d. In Brazil,
the range was between 9 and 25 d, with an overall mean of 10 d
(see Table 9 for individual study data).
In-hospital mortality was 8% (95% CI: 6%–10%, I2 99%, p,
0.001) (Figure 13) across the 23 studies that reported this measure
([20,21,23,29,31,33–35,40,41,43–46,48,50,52,56–58,68–69]; S.
Rahimzadeh, F. Farzadfar F, and M. Ghaziani, unpublished
data), with no significant association with the country-level length
of stay. Four studies reported longer-term outcome data, showing
comparable mortality rates post-discharge: THESUS-HF, a multi-
centre study of heart failure across nine countries of sub-Saharan
Africa, found that mortality from heart failure was 4.2% in
hospital and 17.8% at 6 mo after hospital discharge [35]. In
Brazil, Barretto and colleagues reported a mortality rate of 8.8%
in hospital and 25.8% at 1 y [19], whilst in Pakistan, after almost a
year of follow-up, a similar mortality rate of 27.5% was recorded
[47]. Of the Brazilian cohort studied by de Campos Lopes and
colleagues, 44% were alive at 21 mo of follow-up [42].
Data relating to heart failure as a proportion of total hospital
admissions were available for five countries. Across these
countries, heart failure accounted for 2.2% (range: 0.3%–7.7%)
of total admissions. Brazil was the only LMIC with nationwide
registry data compiled for all patients with heart failure treated by
its public health system [74]. Here, heart failure was responsible
for 2.2% of total hospitalisations across the country [74]. In India,
heart failure accounted for only 0.37% of cases from a sample of
1,551,410 hospitalisations, as derived from billing data in Andhra
Pradesh [69]. Out of a representative sample of 38,926 hospital
admissions in Iran, 0.3% were identified as having heart failure as
the primary cause of admission (S. Rahimzadeh, F. Farzadfar F,
and M. Ghaziani, unpublished data). By contrast, 5.8% of total
hospital admissions in Cameroon were due to heart failure
[24,29], and 7.7% in Argentina [23].
In sub-Saharan Africa, the total number of cardiovascular
admissions was reported, rather than total hospital admissions. In
Nigeria, heart failure accounted for 31% of cardiovascular cases
presenting to hospital [27], with corresponding figures of 38% in
Senegal [38] and 47% in Soweto, South Africa [75].
Population-level data regarding the prevalence of heart failure
were available in only one study, from Turkey [63]. Here an absolute
prevalence of 2.9% for heart failure was found across the sample [63].
Effect of Time on Heterogeneity of Outcomes
Meta-regression was performed to investigate the potential
effect of the time period in which each study was undertaken on
between-study heterogeneity in the causes, management, and
outcomes of heart failure.
A statistically significant effect was observed between the study
time period and hypertension as a cause of heart failure, which
rose by 2.5% per year (95% CI: 1.4%–3.6%, p,0.001) between
1990 and the late 2000s (Figure 14). There was no evidence to
suggest that study time period had a significant effect on the other
main causes of heart failure (IHD: 0.05%, 95% CI: 21.4% to
1.5%, p,0.95; cardiomyopathies: 0.65%, 95% CI: 20.3% to
1.6%, p,0.19; valvular heart disease: 20.04%, 95% CI: 20.7%
to 0.6%, p,0.89) (Figures 15–17).
The reported utilization rates for medical treatments of heart
failure did not differ significantly over time, with the exception of
beta-blockers, which showed an increase of 2.8% per year (95%
CI: 1.5%–4.1%, p,0.001) (Figure 18). Corresponding figures
were 20.4% per year (95% CI: 21.8% to 0.98%, p = 0.56) for
ACEI use and 0.67% (95% CI: 20.9% to 2.2%, p = 0.38) for
mineralocorticoid receptor antagonist use, with loop and/or
thiazide diuretic use changing by 20.49% per year (95% CI: 2
1.9% to 0.9%, p = 0.49) (Figures 19–21).
There was also some evidence to suggest in-hospital mortality
rate declined by 0.28% per year between 1990 and 2010 (95% CI:
20.54% to 20.012%, p = 0.042) (Figure 22).
Discussion
Our study presents, to our knowledge, the most comprehensive
review to date and the first pooled analysis of the burden of heart
failure in LMICs worldwide, collating data on over 230,000
episodes from 31 countries, with representation from all world
regions. We found that heart failure is already a major burden to
populations and health services in LMICs, where it makes up an
average of 2.2% of hospital admissions, affecting more men than
women. Reflecting the broad range of countries included and their
differing levels of socio-economic development, there are wide
variations in patient characteristics and the causes of heart failure
and its management. Nonetheless, noticeable similarities can be
discerned both between the included LMICs themselves and
between these LMICs and HICs.
Across all LMICs from which data were available, the mean age
of patients was 63 y, which is over a decade younger than in
studies from HICs [76,77]. The observed differences in age
between the countries correlated strongly with the differences in
HDI across them. Alongside this is the graded rise in the mean age
of patients from represented low-income, low-middle-income, and
upper-middle-income countries, from 50 y in the former to 60 y
and 70 y, respectively. Thus, the age of presentation in upper-
middle-income countries comes close to that in HICs (70 y in the
EuroHeart Failure Survey II across 30 countries in Europe [76]
and 72 y in ADHERE in the US [77]).
Substantial inter-regional variation is present in the causes
ascribed to individual cases of heart failure. Heart failure is a
syndrome made up of a constellation of signs and symptoms, with
additional features present on further investigation. Given that a
number of its aetiological underpinnings are often potential co-
morbidities, disentangling one from the other is fraught with
challenges, particularly in low-resource environments without
recourse to a broad range of investigative tools [31]. Although
80% of studies from the Americas, Western Pacific, and Europe
reporting aetiologies for heart failure documented the use of
additional investigative tools, only 50% of studies from Africa did
so. Nevertheless, our results are broadly consistent with the
patterns of risk factors reported by Khatibzadeh and colleagues in
their recent review of the worldwide risk factors for heart failure
[78], as well as those of the Global Burden of Disease Study [10].
It is of note that preventable non-communicable diseases, in
particular IHD and hypertension, are responsible for the large
majority of cases worldwide.
Current guidelines worldwide stress the importance of ACEIs,
beta-blockers, and mineralocorticoid receptor antagonists in the
management of heart failure with reduced LVEF, with loop/
thiazide diuretics given for symptom relief. Across the 29 studies
from which management data were available, few studies reported
Heart Failure in Low- and Middle-Income Countries
PLOS Medicine | www.plosmedicine.org 4 August 2014 | Volume 11 | Issue 8 | e1001699
the LVEF of patients, and fewer still separated data by LVEF.
Overall mean LVEF was 40%: 38% amongst inpatients and 48%
amongst those in non-acute settings. Consequently, it is not
possible to make strong conclusions about the adherence of
practice to evidence-based practices worldwide, but it is evident
that management diverges considerably between regions and
remains suboptimal on average. Data from the EuroHeart Failure
Survey II of 30 high-income European countries also demonstrat-
ed poor medical management [76]. In this study, the mean LVEF
of patients was 38%, and just over one-third of patients had a
LVEF.45% [76]. Here, 71% of individuals were prescribed
ACEIs, 48% a mineralocorticoid receptor antagonist, and 61% a
beta-blocker at discharge [76]. The corresponding figures across
our dataset are 57%, 32%, and 34%, respectively.
Across represented LMICs, patients admitted with heart failure
had a poorer immediate prognosis than those in many HICs.
However, as is the case for HICs, the estimates from LMICs
varied substantially, although we found the difference between the
two outlying regions in terms of prognosis, the Americas and
South East Asia, was not statistically significant (p = 0.27). On
average, the in-hospital mortality rate was 8.3% in LMICs,
compared to 6.7% in the EuroHeart Failure II Survey [76] and
4% in ADHERE in the US [77]. Such differences, and the wide
heterogeneity both within LMICs and between LMICs and HICs,
may be due to different thresholds for hospitalisation or differences
in patient characteristics, treatment strategies, or hospital charac-
teristics. Reports of outcomes after hospital discharge were
available from some studies, and these were more comparable to
estimates from HICs [4,6,19,42,47].
Remarkable regional variation exists in the incidence of heart
failure admissions to hospital. Of particular note is the low rate of
reported admissions for heart failure in India and Iran. Unpub-
lished data from India, based on the hospital billing codes assigned
to patients from a sample of just under 1,551,410 admissions,
showed an incidence of 0.37% [69]. Similarly, 0.3% of all hospital
admissions were attributed to heart failure in a registry of over
80,000 hospitalisations across a number of hospitals in Iran (S.
Rahimzadeh, F. Farzadfar F, and M. Ghaziani, unpublished data).
These figures are an order of magnitude smaller than what is
reported in HICs. There are several possible reasons for this
observation. For example, it may be that in these countries,
hospitals are still largely used for procedure-related activities, as
opposed to pure medical management. In such a setting, treatment
of medical conditions, such as heart failure, is much more likely to
take place in the outpatient setting, for which data from India and
Iran are lacking. Overall, the population-level incidence and
prevalence of heart failure, despite its significance and dominance
amongst cardiovascular diseases presenting to hospitals worldwide,
remains largely unknown. Similarly, few data regarding the direct
and indirect costs of heart failure are available in LMICs,
information that is vital in understanding and measuring the value
of different health service configurations and novel interventions.
This review collates data over a time period of almost 20 y,
which may be one explanation for the degree of heterogeneity in
results between studies. However, when study period was analysed
using meta-regression against the causes, management, and
outcomes of heart failure, only three statistically significant effects
were found. These included a rising percentage of patients in
whom hypertension was reported as a contributing cause of heart
failure, an increasing trend in the reported prescription of beta-
blockers over time, and a substantial decline in in-hospital death
rates (see Figures 14, 18, and 22). Although these associations are
plausible and—in case of beta-blocker use and mortality rates—
encouraging, they should be interpreted cautiously because of the
potential for confounding.
Limitations
The data included are derived from a heterogeneous group of
studies that set out with differing research goals. Variation in the
methodologies used, particularly in methods of standardising the
diagnosis and assessment of heart failure, may impact on some of
the findings. These factors likely explain the high estimates of
between-study variation that we found. Such variation may lead
to underestimation of the true prevalence of heart failure, as well
as inaccuracies in the causes ascribed to cases of heart failure.
Our study includes individuals from three groups: those with
their first presentation with acute heart failure, those with acute
decompensation of chronic heart failure, and those with stable
chronic heart failure seen in the outpatient clinic setting.
Differences between healthcare systems may mean that the
characteristics of patients seen in various settings may differ
between countries, whilst adherence to gold-standard manage-
ment may be more common amongst those with stable chronic
heart failure seen in outpatient settings staffed by cardiologists
than amongst those with acute heart failure treated in hospitals
staffed by general internal physicians. In analysing these patients
we have focussed on the evidence-based medical management
methods common to all three groups. Combining data from 1995
to 2014, this study summarises management techniques over an
almost 20-y period, an approach that may underestimate
adherence to current management standards. However, when
evaluated with meta-regression, the heterogeneity in a manage-
ment variable was rarely found to be explained by changes over
time. Another limitation of our study is that our data are derived
from studies conducted for the most part in urban tertiary
referral centres, which may not reflect the broader picture of
heart failure in other hospitals and the community. Finally,
despite the large number of studies included, information from
some regions and for some outcomes was limited. In countries
where few data are available, these results may not be truly
reflective of the population and should therefore be interpreted
as only a guide to the true prevalence, causes, and management
of heart failure.
Conclusion
This review shows that heart failure places a considerable
burden on health systems in LMICs, and affects a wide
demographic profile of patients in these countries. Non-commu-
nicable diseases dominate the causes of heart failure across
LMICs, although infectious valvular diseases and cardiomyopa-
thies continue to impose a significant burden. Together, this
suggests a double burden of communicable and non-communica-
ble diseases for countries in the midst of epidemiological transition.
In addition, we have identified high in-hospital mortality and wide
variation and significant suboptimal use of pharmacological
therapies. Further population-level studies, with clear case and
outcome definitions, are needed for a more accurate assessment of
heart failure in LMICs.
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Figure 1. Data acquisition flowchart.
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Figure 2. Geographic distribution of studies on heart failure in lowand middle-income countries.
doi:10.1371/journal.pmed.1001699.g002
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Figure 3. Male patients by region.
doi:10.1371/journal.pmed.1001699.g003
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Figure 4. Correlation of age and human development index, by country. r = 0.71, p,0.001. The HDI is a measure produced by the United
Nations Development Programme that incorporates gross national income per capita, life expectancy, and time spent in education. It serves as a
single statistic that provides a comparable measure of development across nations. HF, heart failure.
doi:10.1371/journal.pmed.1001699.g004
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Figure 5. Aetiology of heart failure: ischaemic heart disease by region. Percentage of heart failure cases with a documented cause of IHD.
doi:10.1371/journal.pmed.1001699.g005
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Figure 6. Aetiology of heart failure: hypertension by region. Percentage of heart failure cases with a documented cause of hypertension.
doi:10.1371/journal.pmed.1001699.g006
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Figure 7. Aetiology of heart failure: cardiomyopathies by region. Percentage of heart failure cases with a documented cause of
cardiomyopathy.
doi:10.1371/journal.pmed.1001699.g007
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Figure 8. Aetiology of heart failure: valvular heart disease by region. Percentage of heart failure cases with a documented cause of valvular
heart disease.
doi:10.1371/journal.pmed.1001699.g008
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Figure 9. Diuretic use by region. Loop and/or thiazide diuretics. ‘Rahimzadeh S, Farzadfar F, Ghaziani M (2013) Iranian hospital data project
(unpublished data).
doi:10.1371/journal.pmed.1001699.g009
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Figure 10. Angiotensin-converting enzyme inhibitor use by region. ‘Rahimzadeh S, Farzadfar F, Ghaziani M (2013) Iranian hospital data
project (unpublished data).
doi:10.1371/journal.pmed.1001699.g010
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Figure 11. Beta-blocker use by region. ‘Rahimzadeh S, Farzadfar F, Ghaziani M (2013) Iranian hospital data project (unpublished data).
doi:10.1371/journal.pmed.1001699.g011
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Figure 12. Mineralocorticoid receptor antagonist use by region. ‘Rahimzadeh S, Farzadfar F, Ghaziani M (2013) Iranian hospital data project
(unpublished data).
doi:10.1371/journal.pmed.1001699.g012
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Figure 13. In-hospital mortality rates by region. ‘Rahimzadeh S, Farzadfar F, Ghaziani M (2013) Iranian hospital data project (unpublished data).
doi:10.1371/journal.pmed.1001699.g013
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Figure 14. Meta-regression of hypertension against study period.
doi:10.1371/journal.pmed.1001699.g014
Figure 15. Meta-regression of ischaemic heart disease against study period.
doi:10.1371/journal.pmed.1001699.g015
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Figure 16. Meta-regression of cardiomyopathies against study period.
doi:10.1371/journal.pmed.1001699.g016
Figure 17. Meta-regression of valvular heart disease against study period.
doi:10.1371/journal.pmed.1001699.g017
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Figure 18. Meta-regression of beta-blocker use against study period.
doi:10.1371/journal.pmed.1001699.g018
Figure 19. Meta-regression of angiotensin-converting enzyme inhibitor use against study period.
doi:10.1371/journal.pmed.1001699.g019
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Figure 20. Meta-regression of mineralocorticoid receptor antagonist use against study period.
doi:10.1371/journal.pmed.1001699.g020
Figure 21. Meta-regression of diuretic use against study period.
doi:10.1371/journal.pmed.1001699.g021
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Figure 22. Meta-regression of in-hospital mortality rates against study period.
doi:10.1371/journal.pmed.1001699.g022
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Table 7. Included countries grouped by World Health Organization region.
Africa Americas Eastern Mediterranean Europe South East Asia Western Pacific
Algeria Argentina Egypt Romania India China
Cameroon Brazil Iran Turkey Indonesia Malaysia









DRC, Democratic Republic of the Congo.
doi:10.1371/journal.pmed.1001699.t007










Mean age (range), in
years*
52 (42–64) 70 (53–77) 63 (57–69) 67 (61–73) 54 (50–64) 67 (53–74) 63 (42–77)
Number of studies 14 14 4 5 3 7 45
Male
Percent male (95% CI) 51% (43%–59%) 58% (54%–63%) 65% (61%–70%) 61% (48%–73%) 60% (51%–70%) 58% (50%–65%) 58% (54%–62%)















Number of studies 13 16 3 6 3 9 48
LVEF
Mean (range) LVEF, in
percent*
42% (29%–49%) 41% (27%–43%) 50% (34%–55%) 38% (38%–40%) 33% (—) 42% (38%–57%) 40% (27%–57%)




11 (9–13) 10 (5–25) 5 (—) — 3 (—) 23 (13–35) 10 (5–35)
Number of studies 3 6 1 — 1 3 14
*Weighted by study size.
doi:10.1371/journal.pmed.1001699.t008
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Table 9. Characteristics of patients, by country.












Algeria [70]‘ 2008–2009 400 64 60% — 49%
Cameroon [24] 1998–2001 167 57 59% — 23%
Cameroon [29] 2002–2008 462 43 57% 13
Democratic Republic of the
Congo [32]
2003–2004 100 57 48% —
Ghana [30] 1992–1995 572 42 55% —
Nigeria [26] 2006–2008 340 51 51% — 42%
Nigeria [27] 2006–2010 475 49 50% —
Nigeria [22] 2004 102 45 31% —
Nigeria [28] Unspecified 177 52 51% — 45%
Nigeria [31] 2001–2005 423 54 57% —
Nigeria [36] 1995–2005 202 56 54% —
Senegal [38] 2001 170 50 — 11
South Africa [25] 2006 844 55 43% — 45%
Sub-Saharan Africa [35] 2007–2010 1,006 52 49% 9 40%
Americas
Argentina [21] 1996–1997 751 66 41% —
Argentina [43] 2002–2003 615 70 55% —
Argentina [44] 2007 736 — 59% —
Argentina [23] 1992–1999 6,368 77 65%‘ 5
Brazil [39] 2006–2008 166 61 51% — 49%
Brazil [40] 2001 203 67 50% 8*
Brazil [42] 1998–2000 494 58 70% — 34%
Brazil [45] 1992–2010 194,098 — 51% 10
Brazil [46] Unspecified 100 59 56% 9 46%
Brazil [19] 2005–2006 263 60 63% 25 27%
Brazil [59] Unspecified 383 54 53% —
Brazil [66] 1997 100 57 76% — 43%
Brazil [67] 2008 144 61 54% —
Brazil [65] 1995 903 53 60% —
Chile [41] 2002–2004 372 69 59% 11 35%
Chile [70]‘ 2008–2009 199 65 55% — 42%
Colombia [70]‘ 2008–2009 211 70 86% — 46%
Mexico [70]‘ 2008–2009 458 68 43% — 54%
Eastern Mediterranean
Egypt [70]‘ 2008–2009 434 58 66% — 55%
Iran#,‘ 1998–2012 277 67 — 5
Iran [70]‘ 2008–2009 105 57 77% — 34%
Lebanon [70]‘ 2008–2009 181 69 61% — 43%
Pakistan [47] 2002–2003 196 61 65% —
Tunisia [70]‘ 2008–2009 257 67 51% — 53%
Yemen [48] 2007–2008 100 58 65% —
Europe
Romania [50] 2008–2009 3,224 69 56% — 38%
Romania [51] 2006 459 61 86% —
Serbia [61] Unspecified 127 71 73% — 40%
Turkey [49] 1997–1998 661 61 64% — 38%
Turkey [63] 2005 320 — 40% —
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Table 9. Cont.











Turkey [64] 1998–2000 876 64 48% —
South East Asia
India [69]‘ 2008–2012 5,758 50 66% 3
Indonesia [20] 2006 1,687 60 65% — 33%
Thailand [52] 2006–2007 1,612 64 50% —
Western Pacific
China [53] 1995–2009 1,119 65 71% — 38%
China [54] 2008–2009 206 74 56% —
China [55] 2007 478 69 47% —
China [56] 1995–2004 259 70 63% 29
China [57] 1980–2000 1,756 68 56% 35
China [58] 1980–2008 2,458 71 52% 13
China [60] Unspecified 327 — 78% — 57%
China [62] 2008 529 — 30% —
Malaysia [68]‘ 2007–2008 907 61 69% —
Philippines [68]‘ 2006–2007 725 53 55% —
‘Previously unpublished dataset.
*Contributed by author.
#S. Rahimzadeh, F. Farzadfar F, and M. Ghaziani, unpublished data.
doi:10.1371/journal.pmed.1001699.t009










Percent (95% CI) 46% (36%–55%) 31% (19%–43%) 52% (35%–69%) 30% (12%–48%) 12% (10%–14%) 21% (11%–30%) 37% (30%–43%)












Number of studies 13 12 2 3 1 4 33
IHD
Percent (95% CI) 8% (5%–11%) 33% (27%–38%) 59% (46%–71%) 61% (58%–64%) 45% (43%–48%) 54% (37%–71%) 35% (28%–42%)













Number of studies 11 14 2 4 1 5 35
Valvulopathy
Percent (95% CI) 18% (13%–23%) 15% (11%–20%) 22% (14%–30%) 25% (4%–46%) 19% (17%–21%) 21% (8%–34%) 18% (15%–22%)










Number of studies 13 9 2 2 1 4 29
Cardiomyopathy
Percent (95% CI) 24% (19%–29%) 30% (21%–39%) 27% (12%–42%) 7% (3%–12%) 14% (12%–16%) 14% (4%–24%) 24% (20%–29%)










Number of studies 12 7 2 1 1 4 26
doi:10.1371/journal.pmed.1001699.t010
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Editors’ Summary
Background. A healthy heart pumps about 23,000 liters of
blood around the body every day. This blood delivers
oxygen and nutrients to the rest of the body and carries
carbon dioxide and waste products away from the tissues
and organs. A healthy heart is therefore essential for life.
Unfortunately, many people (particularly elderly people)
develop heart failure, a life-threatening condition in which
the heart no longer pumps enough blood to meet all the
body’s needs because it has become too weak or too stiff to
work properly. Heart failure can affect the left, right, or both
sides of the heart, and it can develop slowly (chronic heart
failure) or quickly (acute heart failure). Its symptoms include
swelling (edema) of the feet, ankles, and legs, tiredness, and
shortness of breath. Heart failure, which is most commonly
caused by coronary heart disease (blockage with fatty
deposits of the blood vessels that supply the heart) or high
blood pressure (hypertension), cannot be cured. However,
lifestyle changes (for example, losing weight and avoiding
salty food) and various medications can control heart failure
and improve the quality of life of patients.
Why Was This Study Done? In high-income countries
(HICs), heart failure is a common condition that typically
consumes 1%–2% of healthcare resources. Experts believe
that heart failure may soon become a major public health
issue in low- and middle-income countries (LMICs) because
fewer people are dying of infectious diseases in these
countries than in the past. LMICs need to plan for this
eventuality, but little is known about the current burden of
heart failure in LMICs. Here, the researchers undertake a
systematic review and meta-analysis of published and
unpublished information on the presentation, causes, man-
agement, and outcomes of heart failure in LMICs. A
systematic review uses predefined criteria to identify all the
research on a given topic; a meta-analysis uses statistical
approaches to combine the results of several studies.
What Did the Researchers Do and Find? The researchers
identified 49 published studies and four unpublished
databases that provided information on nearly 240,000
hospitalizations for acute and chronic heart failure in 31
LMICs. Across these LMICs, the average age of patients
admitted to hospital for heart failure was 63 years, more than
ten years younger than the average admission age in HICs.
Differences in mean age at presentation, which ranged from
42 years in Cameroon and Ghana to 75 years in Argentina,
largely correlated with the human development index (a
measure of national well-being) of individual LMICs. Notably,
acute heart failure accounted for 2.2% of all hospital
admissions in the LMICs for which data were available.
Hypertension was the main cause of heart failure in Africa
and the Americas, whereas ischemic heart disease was the
main cause in all other regions. More than two-thirds of
patients were prescribed diuretics for heart failure, whereas
only 57% of patients were treated with angiotensin-
converting enzyme inhibitors, only 34% were treated with
beta-blockers, and only 32% were treated with mineralocor-
ticoid receptor antagonists, the three treatments currently
recommended in guidelines for managing heart failure.
Finally, on average, patients admitted to hospital for heart
failure in LMICs spent ten days in hospital, and 8.3% of them
died in hospital (compared to 6.7% and 4% of similar
patients across Europe and the US, respectively).
What Do These Findings Mean? These findings show
that the presentation, causes, management, and outcomes
of heart failure vary substantially across LMICs. Importantly,
however, these findings reveal that heart failure is already a
major burden in LMICs and that the use of recommended
medications for heart failure is currently suboptimal in these
countries. Because the studies included in this systematic
review and meta-analysis set out to answer different research
questions and used different methods to diagnose heart
failure, the estimates of the burden of heart failure in LMICs
provided here may not be completely accurate. Moreover,
because the data were derived mainly from urban tertiary
referral hospitals, these findings may not reflect the broader
picture of heart failure in the community in LMICs. However,
although additional studies are needed to completely assess
the burden of heart failure in LMICs, the present findings
nevertheless highlight the need to implement better
strategies for the management of heart failure in LMICs.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001699.
N This study is further discussed in a PLOS Medicine
Perspective by Druin Burch
N The US National Heart, Lung, and Blood Institute provides
information for patients about heart failure
N The UK National Health Service Choices website provides
information about all aspects of heart failure
N The American Heart Association, a not-for-profit organiza-
tion, also provides detailed information about heart failure
for patients and their carers
N The British Heart Foundation, a not-for-profit organization,
provides additional information about heart failure,
including a personal story about heart failure; further
personal stories about heart failure are provided by the
not-for-profit organization Healthtalkonline
N Heart Failure Matters provides practical information about
heart failure for patients, families, and caregivers in several
languages; its website includes an animated journey
through heart failure and several personal stories about
the condition
N MedlinePlus provides links to further resources about heart
failure (in English and Spanish)
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